In some recent studies, CCNA2 was suggested to be a prognostic biomarker for liver carcinoma, as it may help in developing an effective therapeutic and/or preventative approach for HCC (Bai et al., 2018b; Zhang et al., 2018; Wu et al., 2019). The gene discussed is CCNA2; the disease is hepatocellular carcinoma.